UOM.MU AS Latvijas Juras medicinas centrs (MUN) €7.40, -5.73% 18 Mar 2026: volume spike demands attention

We saw a sharp intraday move in UOM.MU stock during market hours on 18 Mar 2026, with the price at €7.40 after a -5.73% drop on a volume spike of 9,750 shares. The move widened the gap from the 50-day average €8.44 and pushed the price below the 50-day average while staying above the 200-day average €7.08. In this note we unpack the volume, valuation, short-term technicals, and Meyka AI’s forecast to frame trading and risk management for investors in Germany (MUN).

UOM.MU stock intraday volume spike and price action

The primary driver today was unusual volume: 9,750 shares traded and a reported relative volume of 43,875.44, signalling a true volume spike versus normal activity. The stock fell from the previous close €7.85 to €7.40, a €0.45 decline or -5.73%. Market participants should note the day range was tight at €7.40/€7.40, indicating trade concentration at the lower price.

We connect that volume spike to liquidity: with 800,000 shares outstanding and a market cap of €5,920,000, even modest orders can move price materially on MUN. Traders using a volume-spike strategy should watch order book depth and bid-ask spreads before entering.

UOM.MU stock fundamentals and valuation

AS Latvijas Juras medicinas centrs (UOM.MU) reports EPS €0.57 and a trailing P/E 12.98 on the latest full-quote feed. Book value per share is €8.55 and price-to-book sits near 0.94, suggesting the market values the equity below reported tangible book.

Key ratios: current ratio 0.86, ROE 3.85%, and dividend per share €0.10 (yield ~1.35%). These fundamentals point to modest profitability and conservative leverage (debt reported effectively 0.00 in company metrics), which matters when volume spikes increase downside risk.

Meyka AI grade and UOM.MU stock model forecast

Meyka AI rates UOM.MU with a score out of 100: 72.04 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects monthly €7.46, quarterly €9.86, and yearly €9.12 for UOM.MU stock. Versus the current €7.40, that implies short-term upside of 0.81%, quarterly upside of 33.24%, and annual upside of 23.23%. Forecasts are model-based projections and not guarantees.

UOM.MU stock technicals and trading signals during the spike

Technical indicators show oversold momentum amid the spike: CCI -296.06, MACD histogram -0.05, and ADX 100.00 suggesting a strong directional move. Bollinger Bands place the lower band near €7.60, so the intraday price at €7.40 sits below the lower band and flags short-term oversold conditions.

For a volume-driven trade, we emphasise risk controls: preset stop-loss size, limit entries to visible liquidity, and note the 50-day average €8.44 as the immediate resistance level for any mean-reversion attempt.

Sector context and UOM.MU stock relative performance

UOM.MU trades in the Healthcare sector (Medical – Care Facilities) where the sector average P/E is 29.52 and average current ratio is 2.74. Compared with peers, UOM.MU’s P/B ~0.94 and low leverage stand out as relative value attributes but its current ratio 0.86 is below sector norms, suggesting working capital pressure.

Sector momentum has been mixed year-to-date; investors should weigh defensive healthcare flows against company-specific liquidity and earnings trends when interpreting today’s volume spike.

Practical strategy and price targets for UOM.MU stock trading

Short-term traders reacting to the volume spike can consider a cautious mean-reversion approach with a tight risk budget; a reasonable intraday resistance target is the 50-day average €8.44. For longer-term investors, Meyka AI’s yearly model target €9.12 provides a reference price target and implies +23.23% upside from €7.40.

We recommend position sizing tied to liquidity: limit initial allocations to a small percentage of portfolio and scale only after confirming sustained volume above the stock’s recent average and improved breadth on the order book.

Final Thoughts

Today’s volume spike in UOM.MU stock during market hours on 18 Mar 2026 matters because 9,750 shares traded with a relative volume of 43,875.44, moving the price to €7.40 (down -5.73%). The combination of concentrated trading and a low market cap €5,920,000 raises execution risk for larger orders. Fundamentals show modest profitability (EPS €0.57, P/E 12.98) and attractive price-to-book (0.94), while the current ratio 0.86 flags working capital constraints versus healthcare peers.

Meyka AI’s model projects near-term targets: monthly €7.46, quarterly €9.86, and yearly €9.12, implying up to 33.24% upside to the quarterly forecast. Meyka AI’s grade (72.04, B+, Suggestion: BUY) balances value metrics against operational constraints. These forecasts are model-based projections and not guarantees. If the stock sustains volume above today’s spike and reclaims €8.44 (50-day MA), the outlook improves; if not, downside to the year low €6.00 remains possible. We use this volume-spike event as a prompt to monitor liquidity, confirm trend with follow-through volume, and adjust position sizes accordingly. Meyka AI provides this as an AI-powered market analysis platform view and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.